CN103251765B - 一种治疗腰椎间盘突出症的中药组合物及其制备方法 - Google Patents
一种治疗腰椎间盘突出症的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103251765B CN103251765B CN201310206657.9A CN201310206657A CN103251765B CN 103251765 B CN103251765 B CN 103251765B CN 201310206657 A CN201310206657 A CN 201310206657A CN 103251765 B CN103251765 B CN 103251765B
- Authority
- CN
- China
- Prior art keywords
- group
- parts
- wine
- radix
- processed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 title abstract 3
- 206010050296 Intervertebral disc protrusion Diseases 0.000 title abstract 3
- 239000004863 Frankincense Substances 0.000 claims abstract description 10
- 239000002775 capsule Substances 0.000 claims description 63
- 239000000843 powder Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 229940079593 drug Drugs 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 18
- 241000717739 Boswellia sacra Species 0.000 claims description 17
- 241001489978 Eupolyphaga Species 0.000 claims description 17
- 241001057584 Myrrha Species 0.000 claims description 17
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 17
- 241000180649 Panax notoginseng Species 0.000 claims description 17
- 239000010271 massa medicata fermentata Substances 0.000 claims description 17
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 17
- 239000009286 sanguis draxonis Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 9
- 238000005325 percolation Methods 0.000 claims description 8
- 208000012287 Prolapse Diseases 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 14
- 238000012360 testing method Methods 0.000 abstract description 11
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 208000008035 Back Pain Diseases 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 208000008930 Low Back Pain Diseases 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 26
- 241000700159 Rattus Species 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 19
- 230000002496 gastric effect Effects 0.000 description 17
- 238000001802 infusion Methods 0.000 description 17
- 230000037396 body weight Effects 0.000 description 14
- 239000012153 distilled water Substances 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 208000000114 Pain Threshold Diseases 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000037040 pain threshold Effects 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 208000026137 Soft tissue injury Diseases 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 206010018691 Granuloma Diseases 0.000 description 6
- 238000012449 Kunming mouse Methods 0.000 description 6
- 210000000795 conjunctiva Anatomy 0.000 description 6
- 210000001508 eye Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 240000001624 Espostoa lanata Species 0.000 description 5
- 235000009161 Espostoa lanata Nutrition 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010006464 Hemolysin Proteins Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000018650 Intervertebral disc disease Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310206657.9A CN103251765B (zh) | 2013-05-30 | 2013-05-30 | 一种治疗腰椎间盘突出症的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310206657.9A CN103251765B (zh) | 2013-05-30 | 2013-05-30 | 一种治疗腰椎间盘突出症的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103251765A CN103251765A (zh) | 2013-08-21 |
CN103251765B true CN103251765B (zh) | 2014-06-25 |
Family
ID=48956198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310206657.9A Expired - Fee Related CN103251765B (zh) | 2013-05-30 | 2013-05-30 | 一种治疗腰椎间盘突出症的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103251765B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104116834A (zh) * | 2014-06-27 | 2014-10-29 | 刘刚 | 一种治疗坐骨神经痛的中药组合物 |
CN104606511B (zh) * | 2015-02-09 | 2018-01-26 | 齐刚 | 一种预防微创治疗腰椎间盘突出症术后反跳现象的中药 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1146352A (zh) * | 1996-09-17 | 1997-04-02 | 姚永全 | 骨筋康中药及其制造方法 |
CN1943687A (zh) * | 2005-10-08 | 2007-04-11 | 刘国飞 | 一种治疗腰椎间盘突出的中药组合物及其制备方法 |
-
2013
- 2013-05-30 CN CN201310206657.9A patent/CN103251765B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1146352A (zh) * | 1996-09-17 | 1997-04-02 | 姚永全 | 骨筋康中药及其制造方法 |
CN1943687A (zh) * | 2005-10-08 | 2007-04-11 | 刘国飞 | 一种治疗腰椎间盘突出的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103251765A (zh) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103285060A (zh) | 一种用于活血止痛、去瘀生新的中药组合物及其制备方法 | |
CN103251765B (zh) | 一种治疗腰椎间盘突出症的中药组合物及其制备方法 | |
CN103721084B (zh) | 一种产前护理组合物 | |
CN101912527A (zh) | 一种用于治疗风寒痹阻症的药剂及其制备方法 | |
CN104324149B (zh) | 痛经用药物及其制备方法 | |
CN102885991A (zh) | 一种有效治疗荨麻疹的口服药 | |
CN103705760B (zh) | 一种用于产后会阴疼痛的栓剂制备方法 | |
CN106389651A (zh) | 一种内服外敷用于促进神经外科术后康复的儿童中药 | |
CN115252742B (zh) | 一种用于跌打损伤及骨折的中药口服制剂 | |
CN101045116B (zh) | 一种治疗胆囊炎的中药药物 | |
CN104839483A (zh) | 一种2-3龄鳖的配合饲料及其制备方法 | |
CN110507708A (zh) | 一种治疗乳腺增生的红花逍遥制剂及其制备方法和应用 | |
CN102441089B (zh) | 一种腰椎痹痛中药组合物及其制备方法 | |
CN103239587B (zh) | 一种通络活血胶囊中药组合物的制备方法 | |
CN110025700A (zh) | 一种治疗带状疱疹的外用喷剂 | |
CN102579899A (zh) | 一种骨刺消痛中药组合物及其制备方法 | |
CN103110735B (zh) | 一种治疗痛经的中药组合物及其制备方法 | |
CN103751272B (zh) | 治疗强直性脊柱炎的中药组合物及其提取物 | |
CN105267684A (zh) | 一种治疗肿瘤患者化疗性静脉炎的中药及制备方法 | |
CN117398432A (zh) | 一种用于气血两虚、消肿止痛的中药组合物及其制备方法 | |
CN105687830A (zh) | 一种用于防治气血虚弱型牛焦虫病的药物 | |
CN103768145B (zh) | 治疗强直性脊柱炎的中药制剂 | |
CN104523866A (zh) | 小儿高热惊厥熄风止痉剂及制备 | |
CN104825566A (zh) | 一种蜂针减毒增效口服液及其制备方法 | |
CN102961680B (zh) | 一种治疗胆结石、胆囊炎的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HARBIN KANGBAO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YANG HAIJUAN Effective date: 20150427 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Sui Ming Inventor before: Yang Haijuan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG HAIJUAN TO: SUI MING Free format text: CORRECT: ADDRESS; FROM: 712100 XIANYANG, SHAANXI PROVINCE TO: 150040 HARBIN, HEILONGJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150427 Address after: 150040 No. 63, Wen Jie street, Power District, Heilongjiang, Harbin Patentee after: Harbin Canbo Pharmaceutical Co., Ltd. Address before: 712100 Shaanxi province Xianyang Changle Yangling District Road No. 8 Patentee before: Yang Haijuan |
|
ASS | Succession or assignment of patent right |
Owner name: YAO HONGFENG YAO HONGQING FU WENYUAN FANG YUSHAN S Effective date: 20150723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Sui Ming Inventor after: Yao Hongfeng Inventor after: Yao Hongqing Inventor after: Fu Wenyuan Inventor after: Fang Yushan Inventor before: Sui Ming |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUI MING TO: SUI MING YAO HONGFENG YAO HONGQING FU WENYUAN FANG YUSHAN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150723 Address after: 150040 No. 63, Wen Jie street, Power District, Heilongjiang, Harbin Patentee after: Harbin Canbo Pharmaceutical Co., Ltd. Patentee after: Yao Hongfeng Patentee after: Yao Hongqing Patentee after: Fu Wenyuan Patentee after: Fang Yushan Patentee after: Sui Ming Address before: 150040 No. 63, Wen Jie street, Power District, Heilongjiang, Harbin Patentee before: Harbin Canbo Pharmaceutical Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Harbin Canbo Pharmaceutical Co., Ltd. Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Harbin Canbo Pharmaceutical Co., Ltd. Document name: Notification of Termination of Patent Right |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140625 Termination date: 20160530 |
|
CF01 | Termination of patent right due to non-payment of annual fee |